Faron Pharmaceuticals Oy (LON:FARN) Trading Down 4.9%

Faron Pharmaceuticals Oy (LON:FARN)’s stock price traded down 4.9% during trading on Monday . The company traded as low as GBX 135 ($1.73) and last traded at GBX 135 ($1.73). 615,743 shares traded hands during trading, an increase of 1,017% from the average session volume of 55,146 shares. The stock had previously closed at GBX 142 ($1.82).

Faron Pharmaceuticals Oy Trading Down 4.9 %

The firm has a market capitalization of £97.21 million, a PE ratio of -346.34 and a beta of -0.13. The stock’s 50-day moving average price is GBX 141.88 and its 200 day moving average price is GBX 179. The company has a debt-to-equity ratio of 121.51, a current ratio of 0.59 and a quick ratio of 1.09.

About Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.